Senores Pharmaceuticals Ltd.(IN:SENORES)
₹1,174.70-41.10 (-3.38%)
IN:SENORES
Senores Pharmaceuticals Ltd. financials statements
₹1,174.70
At close:-41.10 (-3.38%)
Want to see IN:SENORES full AI Analyst Report?
Senores Pharmaceuticals Ltd. (SENORES) Financial Statements
1 Followers
Senores Pharmaceuticals Ltd. Financial Overview
Senores Pharmaceuticals Ltd.'s market cap is currently ₹55.99B. The company's EPS TTM is ₹10.35; its P/E ratio is 38.52; Senores Pharmaceuticals Ltd. is estimated to report earnings on January 28, 2027, and the estimated EPS forecast is ₹8.80. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 25 | Mar 25 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | ₹ 3.83B | ₹ 6.33B |
| Gross Profit | ₹ 14.11M | ₹ 3.81B |
| Operating Income | ₹ 728.10M | ₹ 1.37B |
| EBITDA | ₹ 1.08B | ₹ 2.15B |
| Net Income | ₹ 6.85M | ₹ 1.15B |
| Balance Sheet | ||
| Cash & Short-Term Investments | ₹ 3.85B | ₹ 3.32B |
| Total Assets | ₹ 145.66M | ₹ 16.04B |
| Total Debt | ₹ 3.15B | ₹ 3.42B |
| Net Debt | ₹ 24.48M | ₹ 2.96B |
| Total Liabilities | ₹ 50.70M | ₹ 6.39B |
| Stockholders' Equity | ₹ 7.86B | ₹ 9.34B |
| Cash Flow | ||
| Free Cash Flow | ₹ -2.03B | ₹ -2.03B |
| Operating Cash Flow | ₹ -459.20M | ₹ 620.50M |
| Investing Cash Flow | ₹ -4.29B | ₹ -1.21B |
| Financing Cash Flow | ₹ 5.73B | ₹ -13.30M |
Currency in INR
